| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |